Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.

Date publication

janvier 2017

Journal

Annals of surgical oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles , Pr GRAESSLIN Olivier

Tous les auteurs :
Ouldamer L, Bendifallah S, Body G, Canlorbe G, Touboul C, Graesslin O, Raimond E, Collinet P, Coutant C, Lavoué V, Lévêque J, Daraï E, Ballester M,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28058558

Résumé

The European Society of Medical Oncology (ESMO)/European Society of Gynaecological Oncology (ESGO)/European Society for Radiotherapy & Oncology (ESTRO) classification for endometrial cancer (EC) now includes a high-intermediate risk (HIR) group of recurrence due to the adverse prognostic role of lymphovascular space involvement (LVSI) and grade 3 for women at intermediate risk. However, optimal surgical staging, and especially the place of lymphadenectomy, remains to be elucidated. We aimed to establish whether systematic nodal staging should be part of surgical staging for women with HIR EC.

Mots clés

Adult, Aged, Aged, 80 and over, Endometrial Neoplasms, pathology, Female, Follow-Up Studies, Humans, Lymph Node Excision, Lymphatic Metastasis, Medical Oncology, Middle Aged, Neoplasm Invasiveness, Neoplasm Recurrence, Local, pathology, Neoplasm Staging, Prospective Studies, Risk Factors, Sentinel Lymph Node Biopsy, Societies, Medical, Survival Rate

Référence

Ann. Surg. Oncol.. 2017 Jan;: